Leora Horn, MD, on NSCLC: The Path Forward for ALK Inhibitors and Immunotherapy

Posted: Monday, June 11, 2018

Leora Horn, MD, of Vanderbilt University Medical Center, discusses combination regimens for non–small cell lung cancer as well as their multiple toxicities and how they can best be managed.